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Abstract
Introduction: Common variable immunodeficiency encompasses a group of heterogeneous conditions linked by a
lack of immunoglobulin production and primary antibody failure. Although primary immunodeficiencies are
typically characterized by recurrent infections, autoimmune manifestations have increasingly been recognized.
Neurological complications are extremely rare and to the best of our knowledge optic neuritis has not been
described previously. We report the case of a patient with common variable immunodeficiency who developed
loss of vision secondary to bilateral optic neuritis.
Case presentation: A 26-year-old Caucasian man with a diagnosis of common variable immunodeficiency
presented to our facility with loss of vision secondary to bilateral optic neuritis. Results of a thorough study for
infectious, neoplastic and autoimmune diseases were negative. Our patient was treated with intravenous
methylprednisolone with almost complete improvement and he remained asymptomatic at a 12-month follow-up.
Conclusions: Bilateral optic neuritis should be added to the list of autoimmune disorders related to common
variable immunodeficiency. If a patient with common variable immunodeficiency experiences loss of vision, the
possibility of bilateral optic neuritis should be considered as rapid initiation of high-dose corticosteroids may
improve visual recovery.
Introduction
Common variable immunodeficiency (CVID) encom-
passes a group of heterogeneous conditions linked by a
lack of immunoglobulin production and primary anti-
body failure. Although primary immunodeficiencies are
typically characterized by recurrent infections, autoim-
mune manifestations have increasingly been recognized
[1]. The commonest autoimmune conditions in CVID
are hematologic cytopenias. Neurological complications
are extremely rare [2] and to the best of our knowledge
optic neuritis has not been described previously. We
report the case of a patient with CVID who developed
loss of vision secondary to bilateral optic neuritis.
Case presentation
A 26-year-old man with a diagnosis of CVID presented
to our facility with loss of vision in both eyes. The first
manifestation of CVID was hemolytic anemia at the age
of 14, when the diagnosis was made. Later, he experi-
enced several episodes of autoimmune thrombocytope-
nia and neutropenia. Since diagnosis, his only serious
infectious complication had been an episode of salmo-
nella sepsis at the age of 23. Actual treatment included
intravenous immunoglobulin (0.4 g/kg every three
weeks) and prednisone (10 mg daily).
On presentation, our patient reported progressive loss
of vision that had begun five days earlier. He also had
mild pain with eye movement. His visual acuity was 0.1
with reduced color perception, and both pupils showed a
poor response to light stimulation. A confrontational
visual field examination showed a diffusely decreased
visual field in both eyes. Results of a slit-lamp examina-
tion were negative for uveitis. On funduscopic examina-
tion, his optic disk appeared normal. He was afebrile, and
the results of general physical and neurological examina-
tions were normal. There was no family history of eye
disorders.
An MRI of the brain, orbit and spine revealed a mild
enhancement of both optic nerves without other
abnormalities. Pattern-shift visual evoked potentials
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eyes and attenuation of P100 wave amplitude. Labora-
tory investigation results revealed a normal blood count,
and normal levels of liver enzymes, serum creatinine,
angiotensin-converting enzyme, erythrocyte sedimenta-
tion rate, vitamin B12, folate and thyroid hormones.
Serum levels of immunoglobulin were 1590 mg/100 mL,
< 6 mg/100 mL, and 380 mg/100 mL for IgG, IgA and
IgM, respectively. Serum serologies for Lyme, syphilis,
Brucella, viral hepatitis, Bartonella henselae and HIV
were negative. Test results for anti-nuclear antibodies,
rheumatoid factor, anti-nuclear cytoplasmic antibodies,
anti-phospholipid antibodies, anti-CV2, and anti-neuro-
myelitis optica (NMO) antibodies were also all negative.
Fluorescein angiography showed no signs of retinal vas-
culitis. In addition, a chest and abdominal computed
tomography (CT) scan and a whole-body positron emis-
sion tomography (PET) scan were unrevealing. A genetic
study for Leber’s hereditary optic neuropathy was also
negative.
Cerebral spinal fluid (CSF) analysis revealed normal
protein and glucose levels and a white cell count of 2
cells/mm
3 for all lymphocytes. No oligoclonal bands
were present. No malignant cells were observed, and a
microbiological investigation including CSF bacterial,
fungal and mycobacterial cultures was negative. In addi-
tion, CSF PCR tests for enteroviruses, Herpes simplex
virus, varicella zoster, Epstein-Barr, and cytomegalovirus
were all negative.
Our patient was diagnosed with bilateral optic neuri-
tis and treated with intravenous methylprednisolone
(1000 mg/day for five days) and a tapering course of
oral prednisone. Two weeks later, his visual acuity was
one in the right eye and 0.6 in the left eye. Our patient
remained asymptomatic at 12-month follow-up, when
visual acuity was one in the right eye and 0.8 in the
left eye.
Discussion
Bilateral simultaneous optic neuritis is uncommon in
adults [3]. In our patient, there was no evidence of a
toxic, infectious or neoplastic disorder. Sarcoidosis
seemed unlikely in view of the negative chest CT and
PET scan results as well as the normal serum angioten-
sin-converting enzyme levels. Neuromyelitis optica also
seemed improbable considering the normal spinal cord
MRI, negative NMO antibodies and absence of recur-
rent episodes during the follow-up period [4]. Although
CVID has been linked to uveitis [5] and retinal vasculitis
[6], it has to date not been linked to optic neuritis.
Patients with CVID are predisposed to several autoim-
mune disorders, and bilateral optic neuritis should be
added to the list. If a patient with CVID experiences
loss of vision, the possibility of bilateral optic neuritis
should be considered because rapid initiation of high-
dose corticosteroids may improve visual recovery.
Conclusions
This case report describes an unreported complication
of common variable immunodeficiency: bilateral optic
neuritis, linked to the autoimmune manifestation of the
disease. If a patient with common variable immunodefi-
ciency experiences loss of vision, the possibility of bilat-
eral optic neuritis should be considered.
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